Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Potent and selective in vitro activity of 3'-deoxythymidin-2'-ene (3'-deoxy-2',3'-didehydrothymidine) against human immunodeficiency virus.

× No keyword cloud information.

39 in total

Review 1. Clinical pharmacokinetics of stavudine.

Authors: K Z Rana; M N Dudley
Journal: Clin Pharmacokinet Date: 1997-10 Impact factor: 6.447

2. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rats.

Authors: F D Boudinot; S G Smith; E D Funderburg; R F Schinazi
Journal: Antimicrob Agents Chemother Date: 1991-04 Impact factor: 5.191

Review 3. Antiviral therapy for human immunodeficiency virus infections.

Authors: E De Clercq
Journal: Clin Microbiol Rev Date: 1995-04 Impact factor: 26.132

4. In vivo maternal-fetal pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in pigtailed macaques (Macaca nemestrina).

Authors: A Odinecs; C Nosbisch; R D Keller; W L Baughman; J D Unadkat
Journal: Antimicrob Agents Chemother Date: 1996-01 Impact factor: 5.191

5. Radioimmunoassay for quantitation of 2',3'-didehydro-3'-deoxythymidine (D4T) in human plasma.

Authors: X J Zhou; H Chakboub; B Ferrua; J Moravek; R Guedj; J P Sommadossi
Journal: Antimicrob Agents Chemother Date: 1996-06 Impact factor: 5.191

6. High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.

Authors: T Imamichi; T Sinha; H Imamichi; Y M Zhang; J A Metcalf; J Falloon; H C Lane
Journal: J Virol Date: 2000-01 Impact factor: 5.103

Review 7. Approved Antiviral Drugs over the Past 50 Years.

Authors: Erik De Clercq; Guangdi Li
Journal: Clin Microbiol Rev Date: 2016-07 Impact factor: 26.132

8. Computer-aided discovery of anti-HIV agents.

Authors: William L Jorgensen
Journal: Bioorg Med Chem Date: 2016-07-21 Impact factor: 3.641

9. Anti-human immunodeficiency virus type 1 activity and resistance profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro.

Authors: Takao Nitanda; Xin Wang; Hiroki Kumamoto; Kazuhiro Haraguchi; Hiromichi Tanaka; Yung-Chi Cheng; Masanori Baba
Journal: Antimicrob Agents Chemother Date: 2005-08 Impact factor: 5.191

10. Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity.

Authors: Ginger E Dutschman; Susan P Grill; Elizabeth A Gullen; Kazuhiro Haraguchi; Shingo Takeda; Hiromichi Tanaka; Masanori Baba; Yung-Chi Cheng
Journal: Antimicrob Agents Chemother Date: 2004-05 Impact factor: 5.191